Laura Lane

Laura joined Advent in 2019 bringing business intelligence, business development and executive leadership experience.

Prior to joining Advent, Laura held CEO and COO positions at a number of life science and biotech start-ups. This included leading the Series A fundraising and being a founding member of management of VirionHealth. Prior to that, Laura worked at Warwick Ventures focusing on business development and technology commercialisation, and Black Swan Analysis, a boutique consultancy advising pharma and biotech companies on asset valuation and product forecasting.

Laura gained her MSci in Chemistry and PhD in Structural Biology from the University of Cambridge.